A-2311 Alectinib, Hydrochloride Salt, >99%

Synonyms : [AF802] [CH5424802]

Related Terms : [Alecensa]

Prices_reduced
  • Size
  • US $
  • £
  • ¥
  • 25 mg
  • 49
  • 40
  • 35
  • 5,300
  • Add to Cart Qty:
  • In stock
  • 50 mg
  • 63
  • 52
  • 45
  • 6,900
  • Add to Cart Qty:
  • In stock
  • 100 mg
  • 92
  • 76
  • 66
  • 10,000
  • Add to Cart Qty:
  • In stock
  • 200 mg
  • 139
  • 116
  • 100
  • 15,100
  • Add to Cart Qty:
  • In stock
  • 250 mg
  • 161
  • 134
  • 116
  • 17,500
  • Add to Cart Qty:
  • In stock
  • 500 mg
  • 259
  • 216
  • 187
  • 28,200
  • Add to Cart Qty:
  • In stock
  • 1 g
  • 378
  • 315
  • 273
  • 41,100
  • Add to Cart Qty:
  • In stock
  • 2 g
  • 684
  • 571
  • 494
  • 74,400
  • Add to Cart Qty:
  • In stock
  • 5 g
  • 1,240
  • 1,035
  • 896
  • 134,900
  • Add to Cart Qty:
  • In stock

Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.

To receive a Formal Quotation for catalog sizes of this product and/or any other products, please add them to your shopping cart and click on the “REQUEST A QUOTATION” box.
Click Here to Request a Quotation for Larger Quantities Free Shipping and Handling to the U.S. and 33 Other Countries
  • M.W. 519.08
  • C30H34N4O2HCl
  • [1256589-74-8]

Storage: Store at or below -20 ºC. Solubility: Soluble in DMSO.

Select Lot Number to view Certificate of Analysis

View the SDS for this product

  • This research compound is the hydrochloride salt form of alectinib.  Please see the free base form of alectinib, Cat. No. A-2300, Alectrinib, Free Base, for further technical Information.
  • This product is the hydrochloride salt, whose CAS number is given above. The CAS number of Alectinib, Free Base is 1256580-46-7.
  • Related CAS numbers: 1256590-18-7 for the hydrochloride salt, equivalent ratio not specified; 1358953-69-1 for the methanesulfonate salt, equivalent ratio not specified; and 1820744-87-3 for the hydrochloride hydrate salt (1:1:1).
  • Another CAS number previously assigned to alectinib, namely 1416163-60-4, has been deleted by CAS and is no longer in use.
  • Alectinib (as the free base) is the active ingredient in the drug product sold under the trade name Alecensa®.  This drug is currently approved in at least one country for use in patients with anaplastic lymphoma kinase -positive metastatic non-small cell lung cancer.  NOTE:  THE ALECTINIB SOLD BY LC LABORATORIES FOR RESEARCH IS NOT ALECENSA®, AND IS NOT FOR HUMAN USE.

  • Sold for laboratory or manufacturing purposes only; not for human, veterinary, food, or household use.
  • This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (vi) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries.
1268